
### [NCIT:C7183](http://purl.obolibrary.org/obo/NCIT_C7183)
**Label:** Polymorphic Post-Transplant Lymphoproliferative Disorder

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 54.24%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39874](http://purl.obolibrary.org/obo/NCIT_C39874) (Urethral Verrucous Carcinoma))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39873](http://purl.obolibrary.org/obo/NCIT_C39873) (Urethral Glandular Metaplasia))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39872](http://purl.obolibrary.org/obo/NCIT_C39872) (Urethral Villous Adenoma))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39866](http://purl.obolibrary.org/obo/NCIT_C39866) (Female Urethral Malignant Neoplasm))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39864](http://purl.obolibrary.org/obo/NCIT_C39864) (Carcinoma of Cowper Glands))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39862](http://purl.obolibrary.org/obo/NCIT_C39862) (Human Papillomavirus-Related Urethral Squamous Cell Carcinoma))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma))) 37.14%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39856](http://purl.obolibrary.org/obo/NCIT_C39856) (Urothelial Dysplasia))) 37.14%


